AI Insights · Timothy · April 2023
Top 5 Medical Apps on iOS in Dominican Republic Q1 2023
Explore the performance of the top 5 medical apps in the Dominican Republic on iOS during Q1 2023, with insights into downloads, revenue, and active users.
In the first quarter of 2023, the top 5 medical apps on iOS in the Dominican Republic showed varied performance in terms of downloads, revenue, and active users. Below is a detailed analysis of each app's performance, based on data from Sensor Tower.
amma: Pregnancy & Baby Tracker saw significant fluctuations in weekly downloads, peaking at around 2.3K in late January. The app's weekly revenue also experienced notable growth, reaching approximately $153 in the last week of March. Active users steadily increased throughout the quarter, climbing from 13.6K at the start of January to nearly 18.9K by the end of March.
Amadita maintained a consistent download rate, with weekly downloads ranging between 250 and 500. However, there was no recorded revenue or active user data for this app during the quarter.
FarmaValue also showed stable download numbers, with weekly downloads hovering around 260 to 320. Similar to Amadita, there was no recorded revenue or active user data for FarmaValue in this period.
Pregnancy + | Tracker App experienced modest growth in weekly downloads, peaking at 314 in the final week of March. Revenue trends were minimal, with the highest weekly revenue recorded at just $14 in late January. Active users slightly increased from 5.9K at the start of January to around 6.5K by the end of March.
Clarity: CBT Self Help Journal had a varied performance in terms of weekly downloads, reaching a peak of 214 in late January. The app's weekly revenue fluctuated, with the highest point at $179 in early March. Active users showed a gradual increase, rising from 138 at the start of January to 232 by the end of March.
These insights highlight the dynamic nature of the medical app market in the Dominican Republic. For more detailed analytics and insights, visit Sensor Tower.